Functional Differences Between EBV- and CMV-Specific CD8+ T cells Demonstrate Heterogeneity of T cell Dysfunction in CLL
Open Access
- 1 April 2020
- journal article
- research article
- Published by Wiley in HemaSphere
- Vol. 4 (2), e337
- https://doi.org/10.1097/HS9.0000000000000337
Abstract
Acquired T cell dysfunction is a hallmark of chronic lymphocytic leukemia (CLL), and is linked to an increased risk of infections, but also reduced immune surveillance and disappointing responses to autologous T cell-based immunotherapy. The mechanisms of T cell dysfunction in CLL are not well understood. Studying immunity against chronic viruses allows for detailed analysis of the effect of CLL on T cells chronically exposed to a specific antigen. Cytomegalovirus (CMV) reactivations are rare in CLL, which corroborates with preserved CMV-specific T cell function. Epstein-Barr virus (EBV) is another herpesvirus that results in chronic infection, but unlike CMV, is characterized by subclinical reactivations in CLL patients. Since both herpesviruses induce strong CD8(+) T cell responses, but have different clinical outcomes, studying these specific T cells may shed light on the mechanisms of CLL-induced T cell dysfunction. We first analyzed the phenotype of EBV-specific CD8(+) T cells in CLL and healthy controls, and found that in CLL EBV-specific CD8(+) T cells are in an advanced differentiation state with higher expression of inhibitory receptors. Secondly, CLL-derived EBV-specific CD8(+) T cells show reduced cytotoxic potential, in contrast to CMV-specific T cells. Finally, we performed transcriptome analysis to visualize differential modulation by CLL of these T cell subsets. While T cell activation and differentiation genes are unaffected, in EBV-specific T cells expression of genes involved in synapse formation and T cell exhaustion is altered. Our findings on the heterogeneity of antigen specific T cell function in CLL aids in understanding immune-dysregulation in this disease.This publication has 38 references indexed in Scilit:
- T-Cell Responses to EBVPublished by Springer Science and Business Media LLC ,2015
- CD19‐Chimeric Antigen Receptor T Cells for Treatment of Chronic Lymphocytic Leukaemia and Acute Lymphoblastic LeukaemiaScandinavian Journal of Immunology, 2015
- Perturbation of the normal immune system in patients with CLLBlood, 2015
- The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: Insight into disease biology and new targeted therapiesSeminars in Cancer Biology, 2014
- CMV-specific CD8+ T-cell function is not impaired in chronic lymphocytic leukemiaBlood, 2014
- T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine productionBlood, 2013
- The immunodeficiency of chronic lymphocytic leukaemiaBritish Medical Bulletin, 2008
- Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drugJCI Insight, 2008
- Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cellsJCI Insight, 2005
- Role of Cytotoxic T Lymphocytes in Epstein-Barr Virus-Associated DiseasesAnnual Review of Microbiology, 2000